SCHEMBL16102336

SCHEMBL16102336

Cc1c(COC(C)C(O)F)[nH]c(=O)[nH]c1=O

nearest known ligand 0.37

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
▸ L3MBTL1 Q9Y468 1/20 0.37
▸ TYMP P19971 2/20 0.33
▸ ALDH1A1 P00352 1/20 0.30
▸ HPGD P15428 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16102333 0.75 L3MBTL1 (0.36) L3MBTL1TYMP
SCHEMBL14478237 0.65 TYMP (0.45) L3MBTL1TYMP
SCHEMBL21067903 0.64 TYMP (0.39) L3MBTL1TYMP
SCHEMBL6570508 0.63 TYMP (0.46) L3MBTL1TYMP
SCHEMBL20599949 0.62 TYMP (0.45) TYMP
SCHEMBL14709896 0.62 TYMP (0.47) L3MBTL1TYMPALDH1A1HPGD
SCHEMBL7757620 0.61 TYMP (0.41) TYMPALDH1A1HPGD
SCHEMBL4315838 0.61 KDM4E (0.43) L3MBTL1TYMP
SCHEMBL9007002 0.60 TYMP (0.43) L3MBTL1TYMPALDH1A1
SCHEMBL13957603 0.60 GRIA1 (0.46) TYMPALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2970945-B1 IMPROVED THYMIDINE KINASE GENE GENVIVO INC (US) 2024-05-01 — — EP disclosed
US-11253611-B2 Thymidine kinase diagnostic assay for gene therapy applications Genvivo, Inc. (US) 2022-02-22 — — US disclosed
EP-2967078-A1 THYMIDINE KINASE DIAGNOSTIC ASSAY FOR GENE THERAPY APPLICATIONS Epeius Biotechnologies Corporation (US) 2016-01-20 — — EP disclosed
EP-2970945-A2 IMPROVED THYMIDINE KINASE GENE Epeius Biotechnologies Corporation (US) 2016-01-20 — — EP disclosed
WO-2014153258-A2 IMPROVED THYMIDINE KINASE GENE EPEIUS BIOTECHNOLOGIES CORPORATION (US) 2014-09-25 — — WO disclosed
WO-2014153205-A1 THYMIDINE KINASE DIAGNOSTIC ASSAY FOR GENE THERAPY APPLICATIONS EPEIUS BIOTECHNOLOGIES CORPORATION (US) 2014-09-25 — — WO disclosed
Send feedback